Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 6078
Japan Archives - The Pharma Times | Pharma & Health Care News Portal

Japan

International tobacco companies are targeting children with new-age gateway devices to convert them into lifelong customers, say Mothers Against Vaping

New Delhi, December 07,  2023 :  Mothers Against Vaping, a united front of concerned mothers combatting the escalating vaping crisis among…

5 months ago

Eisai: Industry-Academia-Government Joint Development Agreement Aiming for Drug Discovery for Systemic Lupus Erythematosus by Practical Application of Toll-Like Receptor Research Concluded

Tokyo, July 15, 2020: - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an industry-academia-government…

4 years ago

Eisai: Initiation of New Phase III Clinical Study (Ahead 3-45) of ban2401 Preclinical (Asymptomatic) Alzheimer’s Disease

New Delhi, July 14, 2020: The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd., and Biogen Inc. announced today that…

4 years ago

AI-driven Healthcare Analytics firm Tricog raises 10.5 million USD in Series B Funding

The funding will be used to expand the product line for remote patient monitoring and to establish a strong presence…

4 years ago

Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval

- Agreement Extends to Additional Potential Indications for Filgotinib, Including Ulcerative Colitis, Crohn's Disease and Psoriatic Arthritis - Tokyo, December…

4 years ago

Mgm Healthcare Bets Big On Shared Expertise

~ Ropes in specialist from Japan to assist with two complex cardiac procedures ~ Chennai, October 02, 2019: MGM Healthcare,…

5 years ago

Eisai’s Marketing Authorization Application for Potential Insomnia Disorder Treatment Lemborexant Submitted in Japan

New Delhi, March 08, 2019: Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for…

5 years ago

AbbVie and Eisai Announce Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA is the First in Japan to be Approved for the Treatment of Hidradenitis Suppurativa

New Delhi, February 22, 2019: (JCN Newswire) – AbbVie, a research-based global biopharmaceutical company and Eisai Co., Ltd. announced that they…

5 years ago

“Navya Care” Scales Access to Rare Pediatric Cancer Care Expertise To Empower Every Child With Cancer Across India

BANGALORE, Karnataka, February 17, 2019: Navya (www.navya.care) has scaled access to rare pediatric cancer care expertise, enabling every child with cancer…

5 years ago